Literature DB >> 32949254

Risk factors for infection complications after transrectal ultrasound-guided transperineal prostate biopsy.

Xue-Fei Ding1, Yang Luan2, Sheng-Ming Lu1, Guang-Chen Zhou1, Tian-Bao Huang1, Liang-Yong Zhu1, Cheng-Hao Guo1.   

Abstract

BACKGROUND: To investigate the influence factors of infection complications of transrectal ultrasound-guided transperineal prostate biopsy.
METHODS: A total of 2192 patients who underwent prostate biopsy under transperineal prostate biopsy were analyzed retrospectively from December 2010 to May 2020.We collected the clinical characteristics and the incidence of complications, and used univariate and multivariate logistic regression analyses to analyze independent risk factors for infection complications after transperineal prostate biopsy.
RESULTS: Univariate analysis showed that the following factors were associated with the infection complications: diabetes, bacterial prostatitis, history of urinary retention, history of urinary infection, and number of cores. Furthermore, multivariate logistic analysis revealed that diabetes (OR 2.037, 95% CI 1.143-3.572, P = 0.021) and history of urinary retention (OR 2.563, 95% CI 1.284-3.901, P = 0.013) were independent risk factors for infection complications after transperineal prostate biopsy.
CONCLUSIONS: Patients with diabetes and history of urinary retention were more likely to have infection complications after transperineal prostate biopsy.
© 2020. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Diabetes; Infection; Prostate biopsy; Transperineal; Urinary retention

Mesh:

Year:  2020        PMID: 32949254     DOI: 10.1007/s00345-020-03454-y

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  21 in total

1.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

2.  Morbidity of prostate biopsy after simplified versus complex preparation protocols: assessment of risk factors.

Authors:  Osama M Zaytoun; Thomas Anil; Ayman S Moussa; Li Jianbo; Khaled Fareed; J Stephen Jones
Journal:  Urology       Date:  2011-02-12       Impact factor: 2.649

Review 3.  Update on Strategies to Reduce Infectious Complications After Prostate Biopsy.

Authors:  Adrian Pilatz; Rajan Veeratterapillay; Bela Köves; Tommaso Cai; Riccardo Bartoletti; Florian Wagenlehner; Franck Bruyère; Suzanne Geerlings; Gernot Bonkat; Benjamin Pradere
Journal:  Eur Urol Focus       Date:  2018-11-30

4.  Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study.

Authors:  Florian M E Wagenlehner; Edgar van Oostrum; Peter Tenke; Zafer Tandogdu; Mete Çek; Magnus Grabe; Björn Wullt; Robert Pickard; Kurt G Naber; Adrian Pilatz; Wolfgang Weidner; Truls E Bjerklund-Johansen
Journal:  Eur Urol       Date:  2012-06-12       Impact factor: 20.096

5.  Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy.

Authors:  Robert K Nam; Refik Saskin; Yuna Lee; Ying Liu; Calvin Law; Laurence H Klotz; D Andrew Loblaw; John Trachtenberg; Aleksandra Stanimirovic; Andrew E Simor; Arun Seth; David R Urbach; Steven A Narod
Journal:  J Urol       Date:  2013-01       Impact factor: 7.450

6.  EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.

Authors:  Nicolas Mottet; Joaquim Bellmunt; Michel Bolla; Erik Briers; Marcus G Cumberbatch; Maria De Santis; Nicola Fossati; Tobias Gross; Ann M Henry; Steven Joniau; Thomas B Lam; Malcolm D Mason; Vsevolod B Matveev; Paul C Moldovan; Roderick C N van den Bergh; Thomas Van den Broeck; Henk G van der Poel; Theo H van der Kwast; Olivier Rouvière; Ivo G Schoots; Thomas Wiegel; Philip Cornford
Journal:  Eur Urol       Date:  2016-08-25       Impact factor: 20.096

7.  Nonantibiotic Strategies for the Prevention of Infectious Complications following Prostate Biopsy: A Systematic Review and Meta-Analysis.

Authors:  Benjamin Pradere; Rajan Veeratterapillay; Konstantinos Dimitropoulos; Yuhong Yuan; Muhammad Imran Omar; Steven MacLennan; Tommaso Cai; Franck Bruyère; Riccardo Bartoletti; Bela Köves; Florian Wagenlehner; Gernot Bonkat; Adrian Pilatz
Journal:  J Urol       Date:  2020-10-07       Impact factor: 7.450

8.  Risk factors for infectious complications following transrectal ultrasound-guided prostate biopsy.

Authors:  Yu-Peng Wu; Xiao-Dong Li; Zhi-Bin Ke; Shao-Hao Chen; Ping-Zhou Chen; Yong Wei; Jin-Bei Huang; Xiong-Lin Sun; Xue-Yi Xue; Qing-Shui Zheng; Ning Xu
Journal:  Infect Drug Resist       Date:  2018-09-17       Impact factor: 4.003

9.  Cancer incidence and mortality in China, 2014.

Authors:  Wanqing Chen; Kexin Sun; Rongshou Zheng; Hongmei Zeng; Siwei Zhang; Changfa Xia; Zhixun Yang; He Li; Xiaonong Zou; Jie He
Journal:  Chin J Cancer Res       Date:  2018-02       Impact factor: 5.087

Review 10.  Systematic review of complications of prostate biopsy.

Authors:  Stacy Loeb; Annelies Vellekoop; Hashim U Ahmed; James Catto; Mark Emberton; Robert Nam; Derek J Rosario; Vincenzo Scattoni; Yair Lotan
Journal:  Eur Urol       Date:  2013-06-04       Impact factor: 20.096

View more
  6 in total

1.  Antibiotic prophylaxis in patients who had undergone to prostate biopsy in between the EMA warning era: effects of fluoroquinolones in diabetic and non-diabetic patients. Results of an observational cohort study.

Authors:  Riccardo Bartoletti; Francesco Claps; Gabriele Tulone; Alessandro Perotti; Alessandro Zucchi; Niccolò Riccardi; Vincenzo Ficarra; Cosimo De Nunzio; Andrea Tubaro; Alchiede Simonato
Journal:  World J Urol       Date:  2022-06-10       Impact factor: 3.661

Review 2.  Developments in optimizing transperineal prostate biopsy.

Authors:  Emily Cheng; Meenakshi Davuluri; Patrick J Lewicki; Jim C Hu; Spyridon P Basourakos
Journal:  Curr Opin Urol       Date:  2022-01-01       Impact factor: 2.808

3.  Is multiple tract percutaneous nephrolithotomy a safe approach for staghorn calculi?

Authors:  Jian Huang; Shike Zhang; Yapeng Huang; Mehmet Özsoy; Hans-Göran Tiselius; Jinkun Huang; Zhijian Zhao; Tao Zeng; Guohua Zeng; Wenqi Wu
Journal:  World J Urol       Date:  2020-08-28       Impact factor: 4.226

Review 4.  Role of Prophylactic Antibiotics in Transperineal Prostate Biopsy: A Systematic Review and Meta-analysis.

Authors:  Spyridon P Basourakos; Mark N Alshak; Patrick J Lewicki; Emily Cheng; Michael Tzeng; Antonio P DeRosa; Mathew J Allaway; Ashley E Ross; Edward M Schaeffer; Hiten D Patel; Jim C Hu; Michael A Gorin
Journal:  Eur Urol Open Sci       Date:  2022-01-29

5.  Is antibiotic prophylaxis still mandatory for transperineal prostate biopsy? Results of a comparative study.

Authors:  Giacomo M Pirola; Marilena Gubbiotti; Emanuele Rubilotta; Daniele Castellani; Nicolò Trabacchin; Alessandro Tafuri; Alessandro Princiotta; Eugenio Martorana; Filippo Annino; Alessandro Antonelli
Journal:  Prostate Int       Date:  2021-12-07

Review 6.  Hidden in Plants-A Review of the Anticancer Potential of the Solanaceae Family in In Vitro and In Vivo Studies.

Authors:  Tomasz Kowalczyk; Anna Merecz-Sadowska; Patricia Rijo; Mattia Mori; Sophia Hatziantoniou; Karol Górski; Janusz Szemraj; Janusz Piekarski; Tomasz Śliwiński; Michał Bijak; Przemysław Sitarek
Journal:  Cancers (Basel)       Date:  2022-03-11       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.